Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Willing

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Neurology|May 2, 2012
CD8-mediated inflammatory central nervous system disordersAnne Willing, Manuel A Friese
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 3, 2007
Amiloride-sensitive sodium absorption is different in vertebrates and invertebratesKatja Sobczak, Anne Willing, Kristina Kusche, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2018
Production of IL-17 by MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with IL-7 Receptor ExpressionAnne Willing, Jan Jäger, Stefanie Reinhardt, et al.
Seminars in Immunopathology|October 27, 2018
Sex differences in autoimmune disorders of the central nervous systemStefan M Gold, Anne Willing, Frank Leypoldt, et al.
European Journal of Immunology|July 22, 2014
CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosisAnne Willing, Oliver A Leach, Friederike Ufer, et al.
Brain Communications|January 7, 2022
Treating sarcoidosis-associated progressive multifocal leukoencephalopathy with infliximabSina C Rosenkranz, Vivien Häußler, Manuela Kolster, et al.
Med (New York, N.Y.)|March 22, 2021
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosisMax Kaufmann, Hayley Evans, Anna-Lena Schaupp, et al.
Brain : a Journal of Neurology|September 12, 2015
Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell functionMelanie Piédavent-Salomon, Anne Willing, Jan Broder Engler, et al.
Science Immunology|August 8, 2017
Arc/Arg3.1 governs inflammatory dendritic cell migration from the skin and thereby controls T cell activationFriederike Ufer, Pablo Vargas, Jan Broder Engler, et al.
Iscience|December 17, 2024
Identification and development of TRPM4 antagonists to counteract neuronal excitotoxicityLars Binkle-Ladisch, Andy Pironet, Andrea Zaliani, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Neurology|May 2, 2012
CD8-mediated inflammatory central nervous system disordersAnne Willing, Manuel A Friese
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 3, 2007
Amiloride-sensitive sodium absorption is different in vertebrates and invertebratesKatja Sobczak, Anne Willing, Kristina Kusche, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2018
Production of IL-17 by MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with IL-7 Receptor ExpressionAnne Willing, Jan Jäger, Stefanie Reinhardt, et al.
Seminars in Immunopathology|October 27, 2018
Sex differences in autoimmune disorders of the central nervous systemStefan M Gold, Anne Willing, Frank Leypoldt, et al.
European Journal of Immunology|July 22, 2014
CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosisAnne Willing, Oliver A Leach, Friederike Ufer, et al.
Brain Communications|January 7, 2022
Treating sarcoidosis-associated progressive multifocal leukoencephalopathy with infliximabSina C Rosenkranz, Vivien Häußler, Manuela Kolster, et al.
Med (New York, N.Y.)|March 22, 2021
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosisMax Kaufmann, Hayley Evans, Anna-Lena Schaupp, et al.
Brain : a Journal of Neurology|September 12, 2015
Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell functionMelanie Piédavent-Salomon, Anne Willing, Jan Broder Engler, et al.
Science Immunology|August 8, 2017
Arc/Arg3.1 governs inflammatory dendritic cell migration from the skin and thereby controls T cell activationFriederike Ufer, Pablo Vargas, Jan Broder Engler, et al.
Iscience|December 17, 2024
Identification and development of TRPM4 antagonists to counteract neuronal excitotoxicityLars Binkle-Ladisch, Andy Pironet, Andrea Zaliani, et al.
Pageof 2